Igeta M - Search Results

1

The Comprehensive Complication Index in Ulcerative Colitis: A Comparison with the Clavien-Dindo Classification.

Horio Y, Uchino M, Igeta M, Nagano K, Kusunoki K, Kuwahara R, Sato T, Shinzaki S, Ikeuchi H. Horio Y, et al. Among authors: igeta m. Inflamm Intest Dis. 2024 Mar 8;9(1):85-95. doi: 10.1159/000538180. eCollection 2024 Jan-Dec. Inflamm Intest Dis. 2024. PMID: 38590798 Free PMC article.

2

Risk Factors Causing Hypothyroidism in Patients With Head and Neck Cancer After Radiotherapy Using SIB-VMAT.

Yoshimura N, Fujiwara M, Igeta M, Suzuki H, Kunimoto R, Terada T, Shinoda Y, Nakamura M, Fukutake J, Takaki H, Yamakado K. Yoshimura N, et al. Among authors: igeta m. Anticancer Res. 2024 Jan;44(1):323-329. doi: 10.21873/anticanres.16815. Anticancer Res. 2024. PMID: 38159971

3

RAGE in circulating immune cells is fundamental for hippocampal inflammation and cognitive decline in a mouse model of latent chronic inflammation.

Ye D, Miyoshi A, Ushitani T, Kadoya M, Igeta M, Konishi K, Shoji T, Yasuda K, Kitaoka S, Yagi H, Kuroda E, Yamamoto Y, Cheng J, Koyama H. Ye D, et al. Among authors: igeta m. Brain Behav Immun. 2024 Feb;116:329-348. doi: 10.1016/j.bbi.2023.12.022. Epub 2023 Dec 22. Brain Behav Immun. 2024. PMID: 38142917

4

Safety and stable survival of stem-cell-derived retinal organoid for 2 years in patients with retinitis pigmentosa.

Hirami Y, Mandai M, Sugita S, Maeda A, Maeda T, Yamamoto M, Uyama H, Yokota S, Fujihara M, Igeta M, Daimon T, Fujita K, Ito T, Shibatani N, Morinaga C, Hayama T, Nakamura A, Ueyama K, Ono K, Ohara H, Fujiwara M, Yamasaki S, Watari K, Bando K, Kawabe K, Ikeda A, Kimura T, Kuwahara A, Takahashi M, Kurimoto Y. Hirami Y, et al. Among authors: igeta m. Cell Stem Cell. 2023 Dec 7;30(12):1585-1596.e6. doi: 10.1016/j.stem.2023.11.004. Cell Stem Cell. 2023. PMID: 38065067

5

Nocturnal Hypertension and Left Ventricular Diastolic Dysfunction in Patients With Diabetes With the Absence of Heart Failure: Prospective Cohort HSCAA Study.

Kidawara Y, Kadoya M, Igeta M, Morimoto A, Miyoshi A, Kakutani-Hatayama M, Kanzaki A, Konishi K, Kusunoki Y, Daimon T, Asakura M, Ishihara M, Koyama H. Kidawara Y, et al. Among authors: igeta m. Hypertension. 2024 Jan;81(1):172-182. doi: 10.1161/HYPERTENSIONAHA.123.21304. Epub 2023 Nov 22. Hypertension. 2024. PMID: 37990873

6

Analysis of splicing abnormalities in the white matter of myotonic dystrophy type 1 brain using RNA sequencing.

Yoshizumi K, Nishi M, Igeta M, Nakamori M, Inoue K, Matsumura T, Fujimura H, Jinnai K, Kimura T. Yoshizumi K, et al. Among authors: igeta m. Neurosci Res. 2024 Mar;200:48-56. doi: 10.1016/j.neures.2023.10.002. Epub 2023 Oct 6. Neurosci Res. 2024. PMID: 37806497 Free article.

7

Preoperative higher right ventricular stroke work index increases the risk of de novo aortic insufficiency after continuous-flow left ventricular assist device implantation.

Maeda S, Toda K, Shimamura K, Nakamoto K, Igeta M, Sakata Y, Sawa Y, Miyagawa S. Maeda S, et al. Among authors: igeta m. J Artif Organs. 2023 Jul 19. doi: 10.1007/s10047-023-01411-1. Online ahead of print. J Artif Organs. 2023. PMID: 37468735

8

Risk factors for the postoperative recurrence of ulcerative colitis-associated colorectal cancer.

Horio Y, Uchino M, Igeta M, Nagano K, Kusunoki K, Kuwahara R, Kimura K, Kataoka K, Beppu N, Ikeda M, Ikeuchi H. Horio Y, et al. Among authors: igeta m. Int J Colorectal Dis. 2023 May 4;38(1):113. doi: 10.1007/s00384-023-04410-z. Int J Colorectal Dis. 2023. PMID: 37138034

9

Analysis of particle therapy registries based on a unified treatment policy for esophageal cancer.

Tokumaru S, Ishikawa H, Soejima T, Kimoto T, Takakusagi Y, Tamamura H, Wada H, Taguchi H, Uchinami Y, Hiroshima Y, Hojo H, Kamei T, Muto M, Igeta M. Tokumaru S, et al. Among authors: igeta m. J Radiat Res. 2023 Jun 16;64(Supplement_1):i16-i24. doi: 10.1093/jrr/rrad012. J Radiat Res. 2023. PMID: 37036770 Free PMC article.

10

Clinical Efficacy and Safety of Nivolumab in Malignant Non-Pleural Mesothelioma: A Multicenter, Open-Label, Single-Arm, Japanese Phase II Trial (Viola) Protocol.

Kuribayashi K, Igeta M, Daimon T, Ibu M, Suna S, Okamoto R, Kijima T. Kuribayashi K, et al. Among authors: igeta m. Oncology. 2023;101(4):257-261. doi: 10.1159/000528791. Epub 2022 Dec 23. Oncology. 2023. PMID: 36566745

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

30 results

Search Page